RGNX — REGENXBIO INC

Ownership history in Engineers Gate Manager LP  ·  12 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in REGENXBIO INC (RGNX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2019 Q2)
Avg. % of fund
0.02%
First filed
2019 Q2
Last filed
2025 Q3
Quarters held
12
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 29,730 -22,083 -42.6% 0.00% $287K $9.65
2025 Q2 ADDED 51,813 +1,070 +2.1% 0.01% $425K $8.21
2025 Q1 ADDED 50,743 +5,054 +11.1% 0.01% $363K $7.15
2024 Q4 ADDED 45,689 +25,722 +128.8% 0.01% $353K $7.73
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RGNX price (monthly, adj. close)

Other funds also holding RGNX

As of 2025 Q4 — sorted by position size

22NW, LP 3Y 7Y 5.6% Redmile Group, LLC 3Y 7Y 4.63% Lion Point Capital, LP 3Y 7Y 1.98% Propel Bio Management, LLC 1.44% Integral Health Asset Management, LLC 3Y 0.86% ArchPoint Investors 3Y 7Y 0.76% GSK plc 0.49% Pale Fire Capital SE 3Y 0.48% Voss Capital, LP 3Y 0.2% ADAR1 Capital Management, LLC 0.15%
← Back to Engineers Gate Manager LP Holdings